Cited by 2,252Vagus Nerve Stimulation ResearchStress Responses and CortisolCancer, Stress, Anesthesia, and Immune Response

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System

Abstract

The brain and the immune system are the two major adaptive systems of the body. During an immune response the brain and the immune system "talk to each other" and this process is essential for maintaining homeostasis. Two major pathway systems are involved in this cross-talk: the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS). This overview focuses on the role of SNS in neuroimmune interactions, an area that has received much less attention than the role of HPA axis. Evidence accumulated over the last 20 years suggests that norepinephrine (NE) fulfills the criteria for neurotransmitter/neuromodulator in lymphoid organs. Thus, primary and secondary lymphoid organs receive extensive sympathetic/noradrenergic innervation. Under stimulation, NE is released from the sympathetic nerve terminals in these organs, and the target immune cells express adrenoreceptors. Through stimulation of these receptors, locally released NE, or circulating catecholamines such as epinephrine, affect lymphocyte traffic, circulation, and proliferation, and modulate cytokine production and the functional activity of different lymphoid cells. Although there exists substantial sympathetic innervation in the bone marrow, and particularly in the thymus and mucosal tissues, our knowledge about the effect of the sympathetic neural input on hematopoiesis, thymocyte development, and mucosal immunity is extremely modest. In addition, recent evidence is discussed that NE and epi…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0031-6997(24)01470-4

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The size and quality of the intestinal mucus layer is believed to be mediated by sympathetic innervation where mucosal immune system modulation and microbial composition and behavior alterations were seen.

    “The size and quality of the intestinal mucus layer is believed to be mediated by sympathetic innervation where mucosal immune system modulation (Elenkov et al., 2000) and microbial composition and behavior alterations (commensal and pathogenic) were seen (Macfarlane and Dillon, 2007;Rhee et al., 2009)”

    From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Elenkov et al., 2000

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 432

  1. Abadie, 1997, Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from isolated human atrial appendages, Naunyn Schmiedebergs Arch Pharmacol, 355, 384, 10.1007/PL00004958 · DOI
  2. Abbas, 1996, Functional diversity of helper T lymphocytes, Nature (Lond), 383, 787, 10.1038/383787a0 · DOI
  3. Ackerman, 1987, Noradrenergic sympathetic innervation of the spleen: III. Development of innervation in the rat spleen, J Neurosci Res, 18, 49, 10.1002/jnr.490180109 · DOI
  4. Ackerman, 1991, Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation, Brain Behav Immun, 5, 235, 10.1016/0889-1591(91)90021-2 · DOI
  5. Ader, 1982, Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus, Science (Wash DC), 215, 1534, 10.1126/science.7063864 · DOI
  6. Aloe, 1998, Nerve growth factor and autoimmune diseases: Role of tumor necrosis factor-alpha?, Adv Pharmacol, 42, 591, 10.1016/S1054-3589(08)60820-0 · DOI
  7. Aloe, 1997, The expanding role of nerve growth factor from neurotrophic activity to immunologic diseases, Allergy, 52, 883, 10.1111/j.1398-9995.1997.tb01247.x · DOI
  8. Altare, 1998, Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency, Science(Wash DC), 280, 1432, 10.1126/science.280.5368.1432 · DOI
  9. Anastassiou, 1992, Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels, J Immunol, 148, 2845, 10.4049/jimmunol.148.9.2845 · DOI
  10. Anderson, 1986, A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids, Cell, 47, 1079, 10.1016/0092-8674(86)90823-8 · DOI
  11. Arnason, 1988, Immunoregulation in rapidly progressive multiple sclerosis, Ann N Y Acad Sci, 540, 4, 10.1111/j.1749-6632.1988.tb27046.x · DOI
  12. Awatsuji, 1993, Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes, J Neurosci Res, 34, 539, 10.1002/jnr.490340506 · DOI
  13. Baerwald, 1997, Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors, Br J Rheumatol, 36, 1262, 10.1093/rheumatology/36.12.1262 · DOI
  14. Baker, 1995, Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro, J Leukocyte Biol, 57, 395, 10.1002/jlb.57.3.395 · DOI
  15. Barnett, 1997, Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release, J Surg Res, 70, 166, 10.1006/jsre.1997.5118 · DOI
  16. Bartik, 1993, Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: Lack of correlation between inhibition of T cell proliferation and cAMP accumulation, Cell Immunol, 148, 408, 10.1006/cimm.1993.1122 · DOI
  17. Bellinger, 1987, Noradrenergic sympathetic innervation of the spleen: IV. Morphometric analysis in adult and aged F344 rats, J Neurosci Res, 18, 55, 10.1002/jnr.490180110 · DOI
  18. Bellinger, 1988, Maintenance of noradrenergic sympathetic innervation in the involuted thymus of the aged Fischer 344 rat, Brain Behav Immun, 2, 133, 10.1016/0889-1591(88)90014-1 · DOI
  19. Bellinger, 1992, Innervation of lymphoid organs and implications in development, aging, and autoimmunity, Int J Immunopharmacol, 14, 329, 10.1016/0192-0561(92)90162-E · DOI
  20. Bencsics, 1997, Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: Involvement of the sympathetic nervous system, J Neuroimmunol, 73, 1, 10.1016/S0165-5728(96)00163-4 · DOI
  21. Bencsics, 1997, Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes, Brain Res, 761, 236, 10.1016/S0006-8993(97)00313-2 · DOI
  22. Bender, 1993, Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: Role of phosphodiesterase, J Pharmacol Exp Ther, 264, 1381, 10.1016/S0022-3565(25)10155-9 · DOI
  23. Benschop, 1993, Beta 2-adrenergic stimulation causes detachment of natural killer cells from cultured endothelium, Eur J Immunol, 23, 3242, 10.1002/eji.1830231230 · DOI
  24. Benschop, 1996, Catecholamine-induced leukocytosis: Early observations, current research, and future directions, Brain Behav Immun, 10, 77, 10.1006/brbi.1996.0009 · DOI
  25. Berkenbosch, 1989, Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1, Neuroendocrinology, 50, 570, 10.1159/000125283 · DOI · Paper page
  26. Bermudez, 1990, Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor, Lymphokine Res, 9, 137
  27. Besedovsky, 1979, Immunoregulation mediated by the sympathetic nervous system, Cell Immunol, 48, 346, 10.1016/0008-8749(79)90129-1 · DOI
  28. Besedovsky, 1981, Lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels, J Immunology, 126, 385, 10.4049/jimmunol.126.1.385 · DOI
  29. Besedovsky, 1983, The immune response evokes changes in brain noradrenergic neurons, Science (Wash DC), 221, 564, 10.1126/science.6867729 · DOI
  30. Besedovsky, 1975, Changes in blood hormone levels during the immune response, Proc Soc Exp Biol Med, 150, 466, 10.3181/00379727-150-39057 · DOI
  31. Bienenstock, 1989, Nerves and neuropeptides in the regulation of mucosal immunity, Adv Exp Med Biol, 257, 19, 10.1007/978-1-4684-5712-4_4 · DOI
  32. Bischoff, 1992, Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils, Blood, 79, 2662, 10.1182/blood.V79.10.2662.bloodjournal79102662 · DOI
  33. Bismuth, 1988, Cyclic AMP-mediated alteration of the CD2 activation process in human T lymphocytes. Preferential inhibition of the phosphoinositide cycle-related transduction pathway, Eur J Immunol, 18, 1351, 10.1002/eji.1830180908 · DOI
  34. Bissonnette, 1997, Anti-inflammatory effect of beta 2-agonists: Inhibition of TNF-alpha release from human mast cells, J Allergy Clin Immunol, 100, 825, 10.1016/S0091-6749(97)70280-X · DOI
  35. Blandizzi, 1993, Functional evidence that [3H]acetylcholine and [3H]noradrenaline release from guinea pig ileal myenteric plexus and noradrenergic terminals is modulated by different presynaptic alpha-2 adrenoceptor subtypes, J Pharmacol Exp Ther, 267, 1054, 10.1016/S0022-3565(25)39417-6 · DOI
  36. Blennerhassett, 1998, Sympathetic nerve contact causes maturation of mast cells in vitro, J Neurobiol, 35, 173, 10.1002/(SICI)1097-4695(199805)35:2<173::AID-NEU4>3.0.CO;2-1 · DOI
  37. Bondy, 1996, Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction, J Neuroimmunol, 71, 139, 10.1016/S0165-5728(96)00148-8 · DOI
  38. Bonini, 1999, Nerve growth factor: An important molecule in allergic inflammation and tissue remodelling, Int Arch Allergy Immunol, 118, 159, 10.1159/000024055 · DOI
  39. Borger, 1998, Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype, Am J Respir Cell Mol Biol, 19, 400, 10.1165/ajrcmb.19.3.2765 · DOI
  40. Borger, 1996, Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes, Exp Hematol, 24, 108
  41. Bornstein, 1998, Paracrine and neuroendocrine regulation of the adrenal gland—basic and clinical aspects, Horm Metab Res, 30, 292, 10.1055/s-2007-978887 · DOI
  42. Braun, 1998, Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma, Eur J Immunol, 28, 3240, 10.1002/(SICI)1521-4141(199810)28:10<3240::AID-IMMU3240>3.0.CO;2-U · DOI
  43. Brodie, 1996, Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes, FEBS Lett, 394, 117, 10.1016/0014-5793(96)00911-8 · DOI
  44. Brown, 1977, Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation, J Clin Invest, 60, 70, 10.1172/JCI108771 · DOI
  45. Brown, 1991, Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1: Evidence for pituitary-adrenal and sympathetic control, Cell Immunol, 132, 84, 10.1016/0008-8749(91)90008-Y · DOI
  46. Brune, 1999, Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery, Am J Surg, 177, 55, 10.1016/S0002-9610(98)00299-2 · DOI
  47. Bulloch, 1984, Autonomic nervous system innervation of thymic-related lymphoid tissue in wildtype and nude mice, J Comp Neurol, 228, 57, 10.1002/cne.902280107 · DOI
  48. Bullock, 1996, Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion, J Biol Chem, 271, 27500, 10.1074/jbc.271.44.27500 · DOI
  49. Burysek, 1997, Beta-Adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes, FEBS Lett, 411, 83, 10.1016/S0014-5793(97)00671-6 · DOI
  50. Bylund, 1994, IV. International Union of Pharmacology nomenclature of adrenoceptors, Pharmacol Rev, 46, 121, 10.1016/S0031-6997(25)06780-8 · DOI
  51. Byron JW (1971) Evidence for a α2-adrenergic receptor initiating DNA synthesis in haemopoetic stem cells. Exp Cell Res 228–232. · DOI
  52. Calvo, 1969, On the histogenesis of the bone marrow in the rat. Innervation, stroma and their relations to hemopoiesis, Z Zellforsch Mikrosk Anat, 95, 377, 10.1007/BF00995211 · DOI
  53. Carlson, 1989, Neurotransmitter-lymphocyte interactions: Dual receptor modulation of lymphocyte proliferation and cAMP production, J Neuroimmunol, 24, 155, 10.1016/0165-5728(89)90109-4 · DOI
  54. Carlson, 1994, Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells, J Cell Physiol, 161, 39, 10.1002/jcp.1041610106 · DOI
  55. Carpenter, 1998, The influence of nerves on the secretion of immunoglobulin A into submandibular saliva in rats, J Physiol (Lond), 512, 567, 10.1111/j.1469-7793.1998.567be.x · DOI
  56. Casale, 1984, Demonstration that circulating human blood cells have no detectable alpha 1-adrenergic receptors by radioligand binding analysis, J Allergy Clin Immunol, 74, 812, 10.1016/0091-6749(84)90184-2 · DOI
  57. Cavallotti, 1999, Occurrence of adrenergic nerve fibers and of noradrenaline in thymus gland of juvenile and aged rats, Immunol Lett, 70, 53, 10.1016/S0165-2478(99)00127-3 · DOI
  58. Cazaux, 1995, Down-regulation of beta-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes, FEBS Lett, 364, 120, 10.1016/0014-5793(95)00366-H · DOI
  59. Chambers, 1993, Neuroimmune modulation: Signal transduction and catecholamines, Neurochem Int, 22, 95, 10.1016/0197-0186(93)90002-M · DOI
  60. Chan, 1982, Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes, J Cyclic Nucleotide Res, 8, 211
  61. Charon, 1998, Protective effect of neurotrophic factors, neuropoietic cytokines and dibutyryl cyclic AMP on hydrogen peroxide-induced cytotoxicity on PC12 cells: A possible link with the state of differentiation, Neurochem Int, 33, 503, 10.1016/S0197-0186(98)00056-4 · DOI
  62. Chelmicka-Schorr, 1988, Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis, J Neuroimmunol, 17, 347, 10.1016/0165-5728(88)90125-7 · DOI
  63. Chelmicka-Schorr, 1989, The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats, J Neuroimmunol, 25, 203, 10.1016/0165-5728(89)90138-0 · DOI
  64. Chen, 1994, Interleukin 2 transcription factors as molecular targets of cAMP inhibition: Delayed inhibition kinetics and combinatorial transcription roles, J Exp Med, 179, 931, 10.1084/jem.179.3.931 · DOI
  65. Chen, 1989, Distinct patterns of lymphokine requirement for the proliferation of various subpopulations of activated thymocytes in a single cell assay, J Immunol, 143, 1598, 10.4049/jimmunol.143.5.1598 · DOI
  66. Chiolero, 1994, Endocrine response to brain injury, New Horiz, 2, 432
  67. Chou, 1996, Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis, J Neuroimmunol, 67, 7
  68. Chouaib, 1997, The host-tumor immune conflict: From immunosuppression to resistance and destruction, Immunol Today, 18, 493, 10.1016/S0167-5699(97)01115-8 · DOI
  69. Chouaib, 1985, Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: Inhibition of interleukin 2 production and down-regulation of transferrin receptor expression, J Immunol, 135, 1172, 10.4049/jimmunol.135.2.1172 · DOI
  70. Chrousos, 1992, The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis [published erratum appears in JAMA (1992) 268:200], JAMA, 267, 1244, 10.1001/jama.1992.03480090092034 · DOI · Paper page
  71. Chuang, 1996, G protein-coupled receptors:Heterologous regulation of homologous desensitization and its implications, Trends Pharmacol Sci, 17, 416, 10.1016/S0165-6147(96)10048-1 · DOI
  72. Church, 1991, Neuropeptide-induced secretion from human skin mast cells, Int Arch Allergy Appl Immunol, 94, 310, 10.1159/000235393 · DOI
  73. Clauw, 1997, Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms, Neuroimmunomodulation, 4, 134, 10.1159/000097332 · DOI
  74. Clauw, 1996, Tilt table tasting in fibromyalgia, Arthritis Rheum, 39, S276
  75. Clauw, 1996, Heart rate variability as a measure of autonomic dysfunction in patients with fibromyalgia, Arthritis Rheum, 39, S276
  76. Cohen, 1988, Cardiac sympathetic activity during rat pregnancy, Metabolism, 37, 771, 10.1016/0026-0495(88)90013-3 · DOI
  77. Cole, 1998, Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production, J Immunol, 161, 610, 10.4049/jimmunol.161.2.610 · DOI · Paper page
  78. Cole, 1995, Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation, Genes Dev, 9, 1608, 10.1101/gad.9.13.1608 · DOI · Paper page
  79. Colombo, 1996, Amount of interleukin 12 available at the tumor site is critical for tumor regression, Cancer Res, 56, 2531
  80. Cooke, 1986, Neurobiology of the intestinal mucosa, Gastroenterology, 90, 1057, 10.1016/0016-5085(86)90889-9 · DOI
  81. Cook-Mills, 1995, Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma, Cancer Immunol Immunother, 40, 79, 10.1007/BF01520288 · DOI
  82. Coqueret, 1995, Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists, Clin Exp Allergy, 25, 304, 10.1111/j.1365-2222.1995.tb01047.x · DOI
  83. Coqueret, 1994, Regulation of IgE production by beta 2-adrenoceptor agonists, Ann N Y Acad Sci, 725, 44, 10.1111/j.1749-6632.1994.tb39788.x · DOI
  84. Cruz-Aguado, 1999, NGF prevents changes in rat brain glutathione-related enzymes following transection of the septohippocampal pathway, Neurochem Int, 34, 125, 10.1016/S0197-0186(98)00076-X · DOI
  85. Culmsee, 1999, NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: Evidence from an NGF-antisense study, Neurochem Int, 35, 47, 10.1016/S0197-0186(99)00032-7 · DOI
  86. Cunha, 1991, Interleukin-8 as a mediator of sympathetic pain, Br J Pharmacol, 104, 765, 10.1111/j.1476-5381.1991.tb12502.x · DOI
  87. Daaka, 1997, Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A, Nature (Lond), 390, 88, 10.1038/36362 · DOI
  88. Dahlström, 1965, Noradrenaline stores in nerve terminals of the spleen: Changes during hemorrhagic shock, Science (Wash DC), 147, 1583, 10.1126/science.147.3665.1583 · DOI
  89. De Blasi, 1995, Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2, J Clin Invest, 95, 203, 10.1172/JCI117641 · DOI
  90. DeCoursey, 1984, Voltage-gated K+ channels in human T lymphocytes: A role in mitogenesis?, Nature (Lond), 307, 465, 10.1038/307465a0 · DOI
  91. Delgado, 1999, VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression, J Immunol, 163, 4213, 10.4049/jimmunol.163.8.4213 · DOI
  92. Del Rey, 1982, Sympathetic immunoregulation: Difference between high and low-responder animals, Am J Physiol, 242, R30
  93. DeRijk, 1994, Induction of plasma interleukin-6 by circulating adrenaline in the rat, Psychoneuroendocrinology, 19, 155, 10.1016/0306-4530(94)90005-1 · DOI
  94. Ding, 1995, Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor, J Neurobiol, 28, 445, 10.1002/neu.480280405 · DOI
  95. Docherty, 1998, Subtypes of functional alpha1- and alpha2-adrenoceptors, Eur J Pharmacol, 361, 1, 10.1016/S0014-2999(98)00682-7 · DOI
  96. Dougherty, 1953, The quantitative and qualitative responses of blood lymphocytes to stress stimuli, J Lab Clin Med, 42, 530
  97. Dunn, 1998, Brain catecholaminergic and tryptophan responses to restraint are attenuated by nitric oxide synthase inhibition, Neurochem Int, 33, 551, 10.1016/S0197-0186(98)00064-3 · DOI
  98. Dunn, 1988, Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone, Life Sci, 43, 429, 10.1016/0024-3205(88)90522-X · DOI
  99. Dunn, 1999, Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress, Adv Exp Med Biol, 461, 117, 10.1007/978-0-585-37970-8_8 · DOI · Paper page
  100. Ehrenstrom, 1990, Nerve impulse-induced release of endogenous noradrenaline and adrenaline from the perfused cod spleen, J Comp Physiol [B ], 160, 401, 10.1007/BF01075671 · DOI
  101. Ehring, 1998, A nongenomic mechanism for progesterone-mediated immunosuppression: Inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes, J Exp Med, 188, 1593, 10.1084/jem.188.9.1593 · DOI · Paper page
  102. Eigler, 1997, Taming TNF: Strategies to restrain this proinflammatory cytokine, Immunol Today, 18, 487, 10.1016/S0167-5699(97)01118-3 · DOI
  103. Elam, 1992, Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity?, Pain, 48, 371, 10.1016/0304-3959(92)90086-Q · DOI
  104. Elenkov IJ Interface role of noradrenergic innervation in neuro-immune communication. Ph D thesis, 1993.
  105. Elenkov, 1999, Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease, Trends Endocrinol Metab, 10, 359, 10.1016/S1043-2760(99)00188-5 · DOI
  106. Elenkov, 1995, Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice, J Neuroimmunol, 61, 123, 10.1016/0165-5728(95)00080-L · DOI
  107. Elenkov, 1997, Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period?, Mol Med Today, 3, 379, 10.1016/S1357-4310(97)01089-7 · DOI
  108. Elenkov, 1992, Presynaptic inhibitory effect of TNF-alpha on the release of noradrenaline in isolated median eminence, J Neuroimmunol, 41, 117, 10.1016/0165-5728(92)90203-W · DOI
  109. Elenkov, 1992, Lipopolysaccharide is able to bypass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels: Evidence from rats with lesions of the paraventricular nucleus, J Endocrinol, 133, 231, 10.1677/joe.0.1330231 · DOI
  110. Elenkov, 1996, Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications, Proc Assoc Am Physicians, 108, 374
  111. Elenkov, 1991, Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen, Neuropharmacology, 30, 1319, 10.1016/0028-3908(91)90029-B · DOI
  112. Elenkov, 1998, Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors, J Immunol, 161, 2586, 10.4049/jimmunol.161.5.2586 · DOI
  113. Elenkov, 1999, Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: Acute and chronic effects, Ann N Y Acad Sci, 876, 1, 10.1111/j.1749-6632.1999.tb07618.x · DOI
  114. Elliott, 1992, Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination, Cell Mol Neurobiol, 12, 411, 10.1007/BF00711542 · DOI
  115. Engstad, 1999, Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets, Thromb Haemostasis, 81, 139, 10.1055/s-0037-1614431 · DOI
  116. Ernst, 1999, Regulation of the mucosal immune response, Am J Trop Med Hyg, 60, 2, 10.4269/ajtmh.1999.60.2 · DOI
  117. Fabian, 1995, Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: Experimental results and clinical correlation, Surgery, 118, 63, 10.1016/S0039-6060(05)80011-X · DOI
  118. Fearon, 1996, The instructive role of innate immunity in the acquired immune response, Science (Wash DC), 272, 50, 10.1126/science.272.5258.50 · DOI
  119. Fecho, 1993, Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine, J Pharmacol Exp Ther, 265, 1079, 10.1016/S0022-3565(25)38238-8 · DOI
  120. Fecho, 1996, Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats, J Pharmacol Exp Ther, 277, 633, 10.1016/S0022-3565(25)12916-9 · DOI
  121. Fedyk, 1996, Regulation of IgE and cytokine production by cAMP: Implications for extrinsic asthma, Clin Immunol Immunopathol, 81, 101, 10.1006/clin.1996.0165 · DOI
  122. Feldman, 1987, Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes, J Immunol, 139, 3355, 10.4049/jimmunol.139.10.3355 · DOI
  123. Felten, 1992, Noradrenergic and peptidergic innervation of secondary lymphoid organs: Role in experimental rheumatoid arthritis, Eur J Clin Invest, 22, 37
  124. Felten, 1984, Sympathetic innervation of lymph nodes in mice, Brain Res Bull, 13, 693, 10.1016/0361-9230(84)90230-2 · DOI
  125. Felten, 1988, Noradrenergic sympathetic innervation of lymphoid organs, Prog Allergy, 43, 14
  126. Felten, 1987, Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp, J Neurosci Res, 18, 37, 10.1002/jnr.490180108 · DOI
  127. Fink, 1977, Stimulation of erythropoiesis by beta adrenergic agonists. I. Characterization of activity in polycythemic mice, J Pharmacol Exp Ther, 202, 192, 10.1016/S0022-3565(25)30945-6 · DOI
  128. Fink, 1988, Multiple neuropeptides in nerves supplying mammalian lymph nodes: Messenger candidates for sensory and autonomic neuroimmunomodulation?, Neurosci Lett, 90, 39, 10.1016/0304-3940(88)90783-5 · DOI
  129. Fisher, 1982, The thyroid hormone effects on growth and development may be mediated by growth factors, Endocrinol Exp, 16, 259
  130. Fisher, 1995, Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro, Am J Physiol, 268, C910, 10.1152/ajpcell.1995.268.4.C910 · DOI
  131. Foreman, 1987, Substance P and calcitonin gene-related peptide: Effects on mast cells and in human skin, Int Arch Allergy Appl Immunol, 82, 366, 10.1159/000234229 · DOI
  132. Foucart, 1996, Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from mice isolated atria, Naunyn Schmiedebergs Arch Pharmacol, 354, 1, 10.1007/BF00168699 · DOI
  133. Furness, 1980, Types of nerves in the enteric nervous system, Neuroscience, 5, 1, 10.1016/0306-4522(80)90067-6 · DOI
  134. Gaddis, 1982, Presynaptic opiate receptor-mediated inhibition of endogenous norepinephrine and dopamine-beta-hydroxylase release in the cat spleen, independent of the presynaptic alpha adrenoceptors, J Pharmacol Exp Ther, 223, 77, 10.1016/S0022-3565(25)33294-5 · DOI
  135. Genain, 1995, Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor, Proc Natl Acad Sci USA, 92, 3601, 10.1073/pnas.92.8.3601 · DOI
  136. Gibson-Berry, 1993, Modulation of the respiratory burst in human neutrophils by isoproterenol and dibutyryl cyclic AMP, J Neuroimmunol, 43, 59, 10.1016/0165-5728(93)90075-A · DOI
  137. Giron, 1980, Lymph nodes–a possible site for sympathetic neuronal regulation of immune responses, Ann Neurol, 8, 520, 10.1002/ana.410080509 · DOI
  138. Grant, 1997, Differential G-protein expression during B- and T-cell development, Immunology, 90, 564, 10.1046/j.1365-2567.1997.00196.x · DOI
  139. Green, 1994, Effect of E-type prostaglandins on bradykinin-induced plasma extravasation in the knee joint of the rat, Eur J Pharmacol, 252, 127, 10.1016/0014-2999(94)90587-8 · DOI
  140. Green, 1998, Endocrine and vagal controls of sympathetically dependent neurogenic inflammation, Ann N Y Acad Sci, 840, 282, 10.1111/j.1749-6632.1998.tb09568.x · DOI
  141. Grohmann, 2000, IL-9 protects mice from Gram-negative bacterial shock: Suppression of TNF-α, IL-12 and IFN-γ and induction of IL-10, J Immunol, 164, 4197, 10.4049/jimmunol.164.8.4197 · DOI
  142. Hadcock, 1989, Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors, J Biol Chem, 264, 19928, 10.1016/S0021-9258(19)47200-1 · DOI
  143. Hadden, 1970, Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes, Cell Immunol, 1, 583, 10.1016/0008-8749(70)90024-9 · DOI
  144. Haraguchi, 1995, Immunosuppressive retroviral peptides: cAMP and cytokine patterns, Immunol Today, 16, 595, 10.1016/0167-5699(95)80083-2 · DOI
  145. Haraguchi, 1995, Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein [published erratum appears in Proc Natl Acad Sci USA (1995) 92:9009], Proc Natl Acad Sci USA, 92, 3611, 10.1073/pnas.92.8.3611 · DOI
  146. Haraguchi, 1995, Induction of intracellular cAMP by a synthetic retroviral envelope peptide: A possible mechanism of immunopathogenesis in retroviral infections, Proc Natl Acad Sci USA, 92, 5568, 10.1073/pnas.92.12.5568 · DOI
  147. Harvath, 1991, cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness, J Immunol, 146, 224, 10.4049/jimmunol.146.1.224 · DOI
  148. Hasko, 1995, Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice, J Endocrinol, 144, 457, 10.1677/joe.0.1440457 · DOI
  149. Hasko, 1995, Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus, Immunol Lett, 47, 133, 10.1016/0165-2478(95)00085-J · DOI
  150. Hasko, 1998, Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages, Brain Res Bull, 45, 183, 10.1016/S0361-9230(97)00337-7 · DOI
  151. Hasko, 1998, Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism, Br J Pharmacol, 125, 1297, 10.1038/sj.bjp.0702179 · DOI
  152. Hasko, 1996, Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice, Immunol Lett, 49, 143, 10.1016/0165-2478(96)02494-7 · DOI
  153. Hasko, 1996, Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice, J Immunol, 157, 4634, 10.4049/jimmunol.157.10.4634 · DOI
  154. Hasko, 1998, Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro, Br J Pharmacol, 124, 1099, 10.1038/sj.bjp.0701934 · DOI
  155. Hasko, 1998, Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice, J Neuroimmunol, 88, 57, 10.1016/S0165-5728(98)00073-3 · DOI
  156. Hasko, 1998, Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent, Eur J Immunol, 28, 468, 10.1002/(SICI)1521-4141(199802)28:02<468::AID-IMMU468>3.0.CO;2-Z · DOI
  157. Hatfield, 1986, Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro, J Pharmacol Exp Ther, 239, 460, 10.1016/S0022-3565(25)23575-3 · DOI
  158. Hayes, 1994, Elevation of systemic oxygen delivery in the treatment of critically ill patients, N Engl J Med, 330, 1717, 10.1056/NEJM199406163302404 · DOI
  159. Heesen, 1996, Increase of interleukin-6 plasma levels after elective craniotomy: Influence of interleukin-10 and catecholamines, Acta Neurochir (Wien), 138, 77, 10.1007/BF01411728 · DOI
  160. Heijnen, 1996, Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis, J Neuroimmunol, 71, 223, 10.1016/S0165-5728(96)00125-7 · DOI
  161. Heilig, 1993, Sympathetic regulation of T-helper cell function, Brain Behav Immun, 7, 154, 10.1006/brbi.1993.1017 · DOI
  162. Hein, 1998, Gene substitution/knockout to delineate the role of α2-adrenoceptor subtypes in mediating central effects of catecholamine and imidazoles, Ann NY Acad Sci, 881, 265, 10.1111/j.1749-6632.1999.tb09368.x · DOI
  163. Hellstrand, 1989, An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity, Int Arch Allergy Appl Immunol, 89, 334, 10.1159/000234972 · DOI
  164. Hensler, 1998, Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production, J Immunol, 161, 2655, 10.4049/jimmunol.161.5.2655 · DOI
  165. Herrmann, 1989, Neomycin induces high-affinity agonist binding of G-protein-coupled receptors, Eur J Biochem, 185, 677, 10.1111/j.1432-1033.1989.tb15165.x · DOI
  166. Hetier, 1991, Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells, Exp Brain Res, 86, 407, 10.1007/BF00228965 · DOI
  167. Ho, 1998, Substance P C-terminal octapeptide analogues augment tumor necrosis factor-alpha release by human blood monocytes and macrophages, J Neuroimmunol, 82, 126, 10.1016/S0165-5728(97)00175-6 · DOI
  168. Horwitz, 1998, Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus, Arthritis Rheum, 41, 838, 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S · DOI
  169. Hotchkiss, 1995, Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin, Shock, 3, 337
  170. Hurst, 1993, Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves, Am J Physiol, 264, G30
  171. Hurst, 1994, Mechanism underlying tumor necrosis factor-alpha suppression of norepinephrine release from rat myenteric plexus, Am J Physiol, 266, G1123
  172. Ignatowski, 1996, Temporal regulation by adrenergic receptor stimulation of macrophage (M phi)-derived tumor necrosis factor (TNF) production post-LPS challenge, J Neuroimmunol, 65, 107, 10.1016/0165-5728(96)00004-5 · DOI
  173. Ignatowski, 1997, Neuronal-associated tumor necrosis factor (TNF alpha): Its role in noradrenergic functioning and modification of its expression following antidepressant drug administration, J Neuroimmunol, 79, 84, 10.1016/S0165-5728(97)00107-0 · DOI
  174. Ignatowski, 1994, Tumor necrosis factor-alpha: Presynaptic sensitivity is modified after antidepressant drug administration, Brain Res, 665, 293, 10.1016/0006-8993(94)91350-1 · DOI
  175. Irwin, 1994, Stress-induced immune suppression: Role of brain corticotropin releasing hormone and autonomic nervous system mechanisms, Adv Neuroimmunol, 4, 29, 10.1016/S0960-5428(06)80188-9 · DOI
  176. Irwin, 1992, Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: Increased responsivity of the aged rat, Endocrinology, 131, 1047, 10.1210/endo.131.3.1505449 · DOI
  177. Ishida, 1993, Lack of voltage sensitive potassium channels and generation of membrane potential by sodium potassium ATPase in murine T lymphocytes, J Immunol, 151, 610, 10.4049/jimmunol.151.2.610 · DOI
  178. Ishigami, 1919, The influence of psychic acts on the progress of pulmonary tuberculosis, Am Rev Tuberc, 2, 470
  179. Janig, 1992, Characteristics of function-specific pathways in the sympathetic nervous system, Trends Neurosci, 15, 475, 10.1016/0166-2236(92)90092-M · DOI
  180. Janig, 1992, Specialized functional pathways are the building blocks of the autonomic nervous system, J Auton Nerv Syst, 41, 3, 10.1016/0165-1838(92)90121-V · DOI
  181. Jarek, 1993, Endocrine profiles for outcome prediction from the intensive care unit, Crit Care Med, 21, 543, 10.1097/00003246-199304000-00015 · DOI
  182. Jensen, 1999, Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels, Proc Natl Acad Sci USA, 96, 10917, 10.1073/pnas.96.19.10917 · DOI
  183. Jonakait, 1993, Neural-immune interactions in sympathetic ganglia, Trends Neurosci, 16, 419, 10.1016/0166-2236(93)90011-A · DOI
  184. Kable, 2000, In vivo gene modification elucidates subtype-specific functions of α2-adrenergic receptors, J Pharmacol Exp Ther, 293, 1, 10.1016/S0022-3565(24)39196-7 · DOI
  185. Kaliner, 1972, Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV Enhancement of cholinergic and alpha adrenergic stimulation, J Exp Med, 136, 556, 10.1084/jem.136.3.556 · DOI
  186. Kambayashi, 1995, Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages, J Immunol, 155, 4909, 10.4049/jimmunol.155.10.4909 · DOI
  187. Kamikawa, 1998, IL-1beta increases norepinephrine level in rat frontal cortex: Involvement of prostanoids, NO, and glutamate, Am J Physiol, 275, R803
  188. Kang, 1992, NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes, Science (Wash DC), 256, 1452, 10.1126/science.1604322 · DOI
  189. Kannan, 1996, Nerve growth factor and cytokines mediate lymphoid tissue-induced neurite outgrowth from mouse superior cervical ganglia in vitro, J Immunol, 157, 313, 10.4049/jimmunol.157.1.313 · DOI
  190. Kaplanski, 1993, Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event, Blood, 81, 2492, 10.1182/blood.V81.10.2492.2492 · DOI
  191. Karalis, 1991, Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo, Science (Wash DC), 254, 421, 10.1126/science.1925600 · DOI
  192. Karaszewski, 1993, Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis, J Neuroimmunol, 43, 1, 10.1016/0165-5728(93)90068-A · DOI
  193. Karaszewski, 1990, Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis, Ann Neurol, 27, 366, 10.1002/ana.410270404 · DOI
  194. Katafuchi, 1991, Central administration of interferon-alpha enhances rat sympathetic nerve activity to the spleen, Neurosci Lett, 125, 37, 10.1016/0304-3940(91)90125-D · DOI
  195. Katafuchi, 1993, Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat, J Physiol (Lond), 465, 343, 10.1113/jphysiol.1993.sp019680 · DOI
  196. Keller, 1983, Stress-induced suppression of immunity in adrenalectomized rats, Science (Wash DC), 221, 1301, 10.1126/science.6612346 · DOI
  197. Kendall, 1988, The cholinergic and adrenergic innervation of the rat thymus, Adv Exp Med Biol, 237, 255, 10.1007/978-1-4684-5535-9_39 · DOI
  198. Kendall, 1991, Innervation of the rat thymus gland, Brain Behav Immun, 5, 9, 10.1016/0889-1591(91)90004-T · DOI
  199. Khan, 1985, Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells, J Clin Invest, 75, 1578, 10.1172/JCI111863 · DOI
  200. Khan, 1986, Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes, Biochem Pharmacol, 35, 1137, 10.1016/0006-2952(86)90150-4 · DOI

200 of 432 shown

Cited by

Sorted by citations

Metadata

Authors
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S.
Affiliations
  • National Institutes of Health (US)
  • Hungarian Academy of Sciences (HU)
Venue
Pharmacological Reviews
Publisher
Elsevier BV
Published
2000-12
Volume
52
Issue
4
Pages
595-638
ISSN
0031-6997 (ISSN-L)
OpenAlex
W2135514207
Cited by
2,252
References
8
Citations by year
2026: 47 · 2025: 67 · 2024: 62 · 2023: 86 · 2022: 79 · 2021: 86 · 2020: 83 · 2019: 88 · 2018: 76 · 2017: 82 · 2016: 116 · 2015: 98 · 2014: 90 · 2013: 89 · 2012: 128
FWCI
30.23
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacological Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed
Topics
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
Keywords
sympathetic nervous system, neuroimmune interactions, norepinephrine, catecholamines, adrenergic receptors, lymphoid organs, Th1/Th2 balance, cytokine production, antigen-presenting cells, mucosal immunity, thymus, bone marrow, hematopoiesis, hypothalamic-pituitary-adrenal axis
MeSH terms
Animals, Brain, Growth Substances, Hematopoiesis, Humans, Immune System, Immunity, Lymphocytes, Lymphoid Tissue, Neuropeptide Y, Norepinephrine, Receptors, Adrenergic, Sympathetic Nervous System, Signal Transduction, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review